Synthesis and bioactivity of the folate receptor targeted γ-cyclodextrin-folate inclusion-coated CdSe/ZnS quantum dots

Yaoxue Xuebao

Volumn 48, Issue 4, 2013, Pages 566-572

  Zhao, Mei Xia ^a   Li, Yang ^a   Wang, Chao Jie ^a  

^a HENAN UNIVERSITY   (China)

Author keywords

Cyclodextrin; Folic acid; Optical imaging; Quantum dot; Tumor cell line

Indexed keywords

CADMIUM SELENIDE; FOLATE RECEPTOR; FOLIC ACID; GAMMA CYCLODEXTRIN; QUANTUM DOT; ZINC SULFATE; CADMIUM DERIVATIVE; FOLATE RECEPTOR 1; GAMMA CYCLODEXTRIN DERIVATIVE; GAMMA-CYCLODEXTRIN; SELENIUM DERIVATIVE; SULFIDE; ZINC DERIVATIVE; ZINC SULFIDE;

ARTICLE; CYTOTOXICITY; DRUG ACTIVITY; DRUG SYNTHESIS; FLUORESCENCE SPECTROSCOPY; FOURIER TRANSFORMATION; MOLECULARLY TARGETED THERAPY; PARTICLE SIZE; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTUM YIELD; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROSCOPY; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; HELA CELL LINE; HEPG2 CELL LINE; HUMAN; INFRARED SPECTROSCOPY; METABOLISM; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROCEDURES; SYNTHESIS; ULTRAVIOLET SPECTROPHOTOMETRY;

CADMIUM COMPOUNDS; CELL SURVIVAL; FOLATE RECEPTOR 1; FOLIC ACID; GAMMA-CYCLODEXTRINS; HELA CELLS; HEP G2 CELLS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR IMAGING; QUANTUM DOTS; SELENIUM COMPOUNDS; SPECTROPHOTOMETRY, ULTRAVIOLET; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SULFIDES; ZINC COMPOUNDS;

EID: 84878980869     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Han M, Gao X, Su JZ, et al. Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules [J]. Nat Biotechnol, 2001, 19: 631-635. (Pubitemid 32625432)
2. Clarke SJ, Hollmann CA, Zhang Z, et al. Photophysics of dopamine-modified quantum dots and effects on biological systems [J]. Nat Mater, 2006, 5: 409-417.
3. Smith AM, Duan HW, Mohs AM, et al. Bioconjugated quantum dots for in vivo molecular and cellular imaging [J]. Adv Drug Deliv Rev, 2008, 60: 1226-1240.
4. Biju V, Mundayoor S, Omkumar RV, et al. Bioconjugated quantum dots for cancer research: present status, prospects and remaining issues [J]. Biotechnol Adv, 2010, 28: 199-213.
5. Zhao MX, Xia Q, Feng XD, et al. Synthesis, biocompatibility and cell labeling of L-arginine-functional β-cyclodextrin-modified quantum dot probes [J]. Biomaterials, 2010, 31: 4401-4408.
6. Ding RM, He H, Li J. Research progress of polyamidoamine dendrimer in targeting drug delivery system [J]. Acta Pharm Sin, 2011, 46: 493-501.
7. Hashim Z, Howes P, Green M. Luminescent quantum-dot-sized conjugated polymer nanoparticles-nanoparticle formation in a miniemulsion system [J]. J Mater Chem, 2011, 21: 1797-1803.
8. Bruchez M Jr, Moronne M, Gin P, et al. Semiconductor nanocrystals as fluorescent biological labels [J]. Science, 1998, 281: 2013-2016. (Pubitemid 28475485)
9. Chan WC, Nie S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection [J]. Science, 1998, 281: 2016-2018. (Pubitemid 28475486)
10. Tanke HJ, Dirks RW, Raap T. FISH and immunocytochemistry: towards visualizing single target molecules in living cells [J]. Curr Opin Biotech, 2005, 16: 49-54. (Pubitemid 40249759)
11. Somers RC, Bawendi MG, Nocera DG. CdSe nanocrystal based chem-/bio-sensors [J]. Chem Soc Rev, 2007, 36: 579-591.
12. Fan J, Zhou J, Sun T, et al. Multi-spectroscopic study on the interaction between CdTe quantum dots and bovine serum albumin [J]. Chin J Chem, 2010, 28: 2353-2358.
13. Biju V, Itoh T, Ishikawa M. Delivering quantum dots to cells: bioconjugated quantum dots for targeted and nonspecific extracellular and intracellular imaging [J]. Chem Soc Rev, 2010, 39: 3031-3056.
14. Shuhendler AJ, Prasad P, Chan HK, et al. Hybrid quantum dot-fatty ester stealth nanoparticles: toward clinically relevant in vivo optical imaging of deep tissue [J]. ACS Nano, 2011, 5: 1958-1966.
15. Sun XY, Wei LL, Chen HL, et al. Advances in the study of organelles targeting nanocarriers [J]. Acta Pharm Sin, 2009, 44: 838-844.
16. Anas A, Okuda T, Kawashima N, et al. Clathrin-mediated endocytosis of quantum dot-peptide conjugates in living cells [J]. ACS Nano, 2009, 3: 2419-2429.
17. Haun JB, Devaraj NK, Hilderbrand SA, et al. Bioorthogonal chemistry amplifies nanoparticle binding and enhances the sensitivity of cell detection [J]. Nat Nanotech, 2010, 5: 660-665.
18. Liu CY, Pan RR, Jiang TY, et al. Synthesis and characterization of N-octyl-N-arginine chitosan - a chitosan derivant with a mimetic structure of cell-penetrating peptides [J]. Acta Pharm Sin, 2012, 47: 797-802.
19. Lu YJ, Sega E, Leamon CP, et al. Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential [J]. Adv Drug Deliv Rev, 2004, 56: 1161-1176. (Pubitemid 38496513)
20. Li X, Zhang J, Wang DK, et al. Preparation and in vitro properties of folate receptor targeting docetaxel-loaded amphiphilic copolymer-modified liposomes [J]. Acta Pharm Sin, 2012, 47: 1219-1226.
21. Pinhassi RI, Assaraf YG, Farber S, et al. Arabinogalactan-folic acid-drug conjugate for targeted delivery and target-activated release of anticancer drugs to folate receptor-overexpressing cells [J]. Biomacromolecules, 2010, 11: 294-303.
22. Bharali DJ, Lucey DW, Jayakumar H, et al. Folate-receptor-mediated delivery of InP quantum dots for bioimaging using confocal and two-photon microscopy [J]. J Am Chem Soc, 2005, 127: 11364-11371. (Pubitemid 41176898)
23. Pan J, Feng SS. Targeting and imaging cancer cells by folate-decorated, quantum dots (QDs)-loaded nanoparticles of biodegradable polymers [J]. Biomaterials, 2009, 30: 1176-1183.
24. Groc L, Heine M, Cognet L, et al. Differential activity-dependent regulation of the lateral mobilities of AMPA and NMDA receptors [J]. Nat Neurosci, 2004, 7: 695-696. (Pubitemid 38859049)
25. Howarth M, Chinnapen DJ, Gerrow K, et al. A monovalent streptavidin with a single femtomolar biotin binding site [J]. Nat Methods, 2006, 3: 267-273.
26. Qiu AD, Jansen M, Sakaris A, et al. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption [J]. Cell, 2006, 127: 917-928. (Pubitemid 44792250)
27. Sudimack J, Lee RJ. Targeted drug delivery via the folate receptor [J]. Adv Drug Deliv Rev, 2000, 41: 147-162. (Pubitemid 30122955)
28. Fu H, Zhou YH, Chen WL, et al. Complexation, structure and SOD activity of the imidazolate-bridged dinuclear copper moiety with β-cyclodextrin and its guanidinium-containing derivative [J]. J Am Chem Soc, 2006, 128: 4924-4925.
29. Zhao MX, Ji LN, Mao ZW. β-Cyclodextrin/glycyrrhizic acid functionalized quantum dots selectively enter hepatic cells and induce apoptosis [J]. Chem Eur J, 2012, 18: 1650-1658.
30. Zhao MX, Li JM, Du L, et al. Targeted cellular uptake and siRNA silencing by quantum dots nanoparticles coated with β-cyclodextrin coupled to amino acid [J]. Chem Eur J, 2011, 17: 5171-5179.
31. Wang QF, Li SM, Zhang YY, et al. Modulating drug loading and release profile of β-cyclodextrin polymers by means of cross-linked degree [J]. Acta Pharm Sin, 2011, 46: 221-226.
32. Dorokhin D, Hsu SH, Tomczak N, et al. Fabrication and luminescence of designer surface patterns with β-cyclodextrin functionalized quantum dots via multivalent supramolecular coupling [J]. ACS Nano, 2010, 4: 137-142.
33. Loftsson T, Duchêne D. Cyclodextrins and their pharmaceutical applications [J]. Int J Pharm, 2007, 329: 1-11. (Pubitemid 44937538)
34. Gao YY, Liu LH, Ou ZZ, et al. Biological activity of a cholesterol modified fullerence/γ-cyclodextrin inclusion complex [J]. Acta Phys Chim Sin 2010, 26: 495-501.
35. Zhao MX, Huang HF, Xia Q, et al. γ-Cyclodextrin/folate complex-functionalized quantum dots for tumor-targeting and site-specific labeling [J]. J Mater Chem, 2011, 21: 10290-10297.
36. Choi HS, Liu WH, Misra P, et al. Renal clearance of quantum dots [J]. Nat Biotechnol, 2007, 25: 1165-1170. (Pubitemid 47538116)
37. Frangioni JV. New technologies for human cancer imaging [J]. J Clin Oncol, 2008, 26: 4012-4021.
38. Peng XG, Schlamp MC, Kadavanich AV, et al. Epitaxial growth of highly luminescent CdSe/CdS core/shell nanocrystals with photostability and electronic accessibility [J]. J Am Chem Soc, 1997, 119: 7019-7029. (Pubitemid 27357292)
39. Conroy J, Byrne SJ, Gun'ko YK, et al. CdTe nanoparticles display tropism to core histones and histone-rich cell organelles [J]. Small, 2008, 4: 2006-2015.
40. Quarta A, Ragusa A, Deka S, et al. Bioconjugation of rod-shaped fluorescent nanocrystals for efficient targeted cell labeling [J]. Langmuir, 2009, 25: 12614-12622.
41. Kapitonov AM, Stupak AP, Gaponenko SV, et al. Luminescence properties of thiol-stabilized CdTe nanocrystals [J]. J Phys Chem B, 1999, 103: 10109-10113. (Pubitemid 129614058)
42. Wuister SF, Swart I, van Driel F, et al. Highly luminescent water-soluble CdTe quantum dots [J]. Nano Lett, 2003, 3: 503-507. (Pubitemid 37140652)
43. Makhal A, Yan H, Lemmens P, et al. Light harvesting semiconductor core-shell nanocrystals: ultrafast charge transport dynamics of CdSe-ZnS quantum dots [J]. J Phys Chem C, 2010, 114: 627-632.
44. Kirchner C, Liedl T, Kudera S, et al. Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles [J]. Nano Lett, 2005, 5: 331-338. (Pubitemid 40308295)
45. Lovrić J, Bazzi HS, Cuie Y, et al. Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots [J]. J Mol Med, 2005, 83: 377-385. (Pubitemid 41201802)
46. Pinaud F, King D, Moore HP, et al. Bioactivation and cell targeting of semiconductor CdSe/ZnS nanocrystals with phytochelatin-related peptides [J]. J Am Chem Soc, 2004, 126: 6115-6123. (Pubitemid 38637980)
47. Yao T, Zhao Q, Qiao Z, et al. Chemical synthesis, structural characterization, optical properties, and photocatalytic activity of ultrathin ZnSe nanorods [J]. Chem Eur J, 2011, 17: 8663-8670.